Beijing HyperStrong Technology
688411
Yalian Machinery
001395
Merit Interactive
300766
Pansoft
300996
Sublime China Information
301299
CN Stock MarketDetailed Quotes
002566 Jilin Jian Yisheng Pharmaceutical
- 6.74
- +0.09+1.35%
Market Closed Jan 27 15:00 CST
2.23BMarket Cap30.92P/E (TTM)
6.84High6.67Low32.33KlotVolume6.69Open6.65Pre Close21.88MTurnover1.40%Turnover Ratio23.57P/E (Static)330.95MShares8.0252wk High1.01P/B1.56BFloat Cap5.0552wk Low7.32Limit Up231.79MShs Float26.46Historical High5.99Limit Down2.56%Amplitude5.05Historical Low0.15Dividend TTM6.77Avg Price13.86KlotAsk2.23%Div YieldTTM100Lot Size16.53KlotBid
Jilin Jian Yisheng Pharmaceutical Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -22.36%505.56M | -25.90%347.84M | -20.16%200.39M | 2.85%853.66M | 4.53%651.15M | 9.57%469.43M | 11.28%250.97M | -5.45%830.04M | -7.51%622.93M | -5.82%428.41M |
| Operating revenue | -22.36%505.56M | -25.90%347.84M | -20.16%200.39M | 2.85%853.66M | 4.53%651.15M | 9.57%469.43M | 11.28%250.97M | -5.45%830.04M | -7.51%622.93M | -5.82%428.41M |
| Other operating revenue | ---- | 26.87%1.1M | ---- | 210.21%3.03M | ---- | 335.87%870.38K | ---- | -64.94%977.98K | ---- | 18.01%199.69K |
| Total operating cost | -18.73%487.97M | -23.68%326.29M | -19.49%178.72M | 3.20%770.98M | 7.65%600.42M | 11.76%427.5M | 11.09%221.98M | -2.86%747.05M | -5.90%557.74M | -4.93%382.52M |
| Operating cost | -28.59%127.43M | -38.62%81.05M | -34.31%46.39M | 3.55%224.2M | 11.12%178.45M | 21.70%132.05M | 31.77%70.62M | -1.82%216.53M | -4.28%160.6M | 0.98%108.51M |
| Operating tax surcharges | -11.12%12.2M | -16.00%8.15M | -12.80%4.45M | 5.79%17.46M | 10.52%13.73M | 12.87%9.71M | 20.08%5.11M | -2.28%16.5M | -7.75%12.42M | -7.25%8.6M |
| Operating expense | -20.06%250.45M | -22.16%173.8M | -15.61%96.33M | 5.78%411.4M | 7.56%313.31M | 8.27%223.28M | 5.13%114.14M | -6.22%388.92M | -9.18%291.3M | -7.88%206.22M |
| Administration expense | -0.25%79.16M | 2.40%52.68M | 5.44%27.46M | -0.27%100.13M | 8.94%79.36M | 12.60%51.45M | -1.60%26.04M | 9.57%100.41M | 2.05%72.85M | -5.83%45.69M |
| Financial expense | 1,945.90%4.35M | 133.34%1.04M | -221.99%-914.74K | -115.14%-896.28K | -95.82%212.69K | -88.45%447.35K | -71.27%749.88K | 35.89%5.92M | 13.59%5.09M | 90.27%3.87M |
| -Interest expense (Financial expense) | 2.21%10.46M | 1.09%6.86M | -21.79%2.83M | -2.65%13.66M | -1.49%10.23M | -3.62%6.79M | -3.05%3.62M | 5.04%14.03M | 8.56%10.39M | 11.66%7.04M |
| -Interest Income (Financial expense) | 38.46%-6.23M | 7.40%-5.92M | -26.50%-3.74M | -78.87%-14.67M | -88.18%-10.11M | -98.06%-6.4M | -156.06%-2.96M | 10.70%-8.2M | -4.47%-5.38M | 25.39%-3.23M |
| Research and development | -6.34%14.38M | -9.54%9.55M | -5.90%5.01M | -0.53%18.68M | -0.85%15.35M | 9.78%10.56M | 22.57%5.32M | -10.12%18.78M | 3.97%15.48M | -14.02%9.62M |
| Credit Impairment Loss | -109.54%-147.51K | -114.84%-349.42K | 34.98%-945.36K | 178.32%2.42M | 131.37%1.55M | 149.88%2.35M | 15.99%-1.45M | -499.80%-3.09M | -23.52%-4.93M | -16.00%-4.72M |
| Asset Impairment Loss | ---- | ---- | ---- | -8.50%994.12K | ---- | ---- | ---- | 258.16%1.09M | ---- | ---- |
| Other net revenue | 1.33%22.65M | 1.01%19.01M | -56.55%4.66M | 67.91%33.04M | 82.65%22.35M | 88.70%18.82M | 34.87%10.73M | -0.20%19.68M | 60.76%12.24M | 63.59%9.98M |
| Fair value change income | -76.21%263.24K | -1,065.87%-411.13K | -163.69%-739.23K | 1,081.15%3.14M | 778.40%1.11M | -90.88%42.57K | 49.42%1.16M | -296.16%-319.94K | ---163.1K | --466.9K |
| Invest income | 156.11%4.79M | 151.09%4.7M | --1.97M | -44.32%1.64M | -34.43%1.87M | -9.39%1.87M | ---- | 3,431.83%2.94M | --2.85M | --2.07M |
| Asset deal income | --381.49K | --381.49K | ---- | --779.7K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other revenue | -2.63%17.36M | 0.94%14.69M | -60.34%4.37M | 26.32%24.08M | 23.14%17.83M | 19.69%14.56M | 29.65%11.02M | -1.69%19.06M | 24.76%14.48M | 19.63%12.16M |
| Operating profit | -44.94%40.24M | -33.22%40.57M | -33.72%26.33M | 12.73%115.73M | -5.61%73.08M | 8.74%60.75M | 17.98%39.72M | -20.19%102.66M | -12.42%77.43M | -4.74%55.87M |
| Add:Non operating Income | -72.86%67.09K | 100.23%46.76K | 5,324.60%368.14K | -98.47%1.38K | 220.71%247.23K | -60.82%23.35K | -89.61%6.79K | -81.91%90.58K | -78.16%77.09K | -35.49%59.6K |
| Less:Non operating expense | -39.23%1.93M | -44.44%1.74M | -43.91%1.69M | 159.56%3.97M | 267.45%3.18M | 699.96%3.13M | 3,219.90%3.02M | -73.47%1.53M | -80.54%864.48K | -86.97%390.85K |
| Total profit | -45.29%38.38M | -32.56%38.88M | -31.89%25M | 10.41%111.76M | -8.46%70.15M | 3.80%57.65M | 9.13%36.71M | -17.95%101.23M | -9.11%76.64M | -0.36%55.54M |
| Less:Income tax cost | -50.00%4.98M | -28.17%5.52M | -32.59%3.59M | 21.27%15.65M | -7.42%9.95M | -0.58%7.68M | 20.57%5.32M | -30.88%12.91M | 8.12%10.75M | 18.19%7.73M |
| Net profit | -44.51%33.4M | -33.23%33.36M | -31.78%21.42M | 8.82%96.11M | -8.63%60.2M | 4.51%49.97M | 7.40%31.39M | -15.64%88.32M | -11.41%65.89M | -2.83%47.81M |
| Net profit from continuing operation | -44.51%33.4M | -33.23%33.36M | -31.78%21.42M | 8.82%96.11M | -8.63%60.2M | 4.51%49.97M | 7.40%31.39M | -15.64%88.32M | -11.41%65.89M | -2.83%47.81M |
| Less:Minority Profit | -242.37%-2.46M | -98.98%25.91K | -85.12%400.03K | -73.62%1.38M | -68.85%1.73M | -36.53%2.54M | 34.48%2.69M | -39.80%5.22M | -39.14%5.55M | -48.95%4M |
| Net profit of parent company owners | -38.66%35.86M | -29.71%33.34M | -26.78%21.02M | 14.00%94.73M | -3.09%58.47M | 8.25%47.43M | 5.41%28.7M | -13.46%83.1M | -7.54%60.33M | 5.90%43.81M |
| Earning per share | ||||||||||
| Basic earning per share | -38.65%0.1084 | -29.73%0.1007 | -26.76%0.0635 | 13.98%0.2862 | -3.07%0.1767 | 8.23%0.1433 | 5.35%0.0867 | -13.44%0.2511 | -7.56%0.1823 | 5.92%0.1324 |
| Diluted earning per share | -38.65%0.1084 | -29.73%0.1007 | -26.76%0.0635 | 13.98%0.2862 | -3.07%0.1767 | 8.23%0.1433 | 5.35%0.0867 | -13.44%0.2511 | -7.56%0.1823 | 5.92%0.1324 |
| Other composite income | ||||||||||
| Total composite income | -44.51%33.4M | -33.23%33.36M | -31.78%21.42M | 8.82%96.11M | -8.63%60.2M | 4.51%49.97M | 7.40%31.39M | -15.64%88.32M | -11.41%65.89M | -2.83%47.81M |
| Total composite income of parent company owners | -38.66%35.86M | -29.71%33.34M | -26.78%21.02M | 14.00%94.73M | -3.09%58.47M | 8.25%47.43M | 5.41%28.7M | -13.46%83.1M | -7.54%60.33M | 5.90%43.81M |
| Total composite income of minority owners | -242.37%-2.46M | -98.98%25.91K | -85.12%400.03K | -73.62%1.38M | -68.85%1.73M | -36.53%2.54M | 34.48%2.69M | -39.80%5.22M | -39.14%5.55M | -48.95%4M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | China Audit Zhonghuan Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
